Les grandes phases III
L'espace médecins du GCC
Retrouvez ici les grandes phases III.
COLOMBUS Phase III
Septembre 2024
Patients with unresectable or metastasic BRAF V600-mutant melanoma phase III encorafenib + binimetinib
JAVELIN Phase II
Septembre 2024
Résultats longs termes de l’essai à 4 ans
First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 study
First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 study
